Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response
JA Halsall, N Turan, M Wiersma, BM Turner - Epigenetics & chromatin, 2015 - Springer
Background The genome-wide hyperacetylation of chromatin caused by histone
deacetylase inhibitors (HDACi) is surprisingly well tolerated by most eukaryotic cells. The …
deacetylase inhibitors (HDACi) is surprisingly well tolerated by most eukaryotic cells. The …
Epigenomics in stress tolerance of plants under the climate change
Background Climate change has had a tremendous impact on the environment in general
as well as agricultural crops grown in these situations as time passed. Agricultural …
as well as agricultural crops grown in these situations as time passed. Agricultural …
Molecular basis for substrate recognition by lysine methyltransferases and demethylases
PA Del Rizzo, RC Trievel - Biochimica et Biophysica Acta (BBA)-Gene …, 2014 - Elsevier
Lysine methylation has emerged as a prominent covalent modification in histones and non-
histone proteins. This modification has been implicated in numerous genomic processes …
histone proteins. This modification has been implicated in numerous genomic processes …
Molecular mechanisms underlying the fetal programming of adult disease
T Vo, DB Hardy - Journal of cell communication and signaling, 2012 - Springer
Adverse events in utero can be critical in determining quality of life and overall health. It is
estimated that up to 50% of metabolic syndrome diseases can be linked to an adverse fetal …
estimated that up to 50% of metabolic syndrome diseases can be linked to an adverse fetal …
Crystal structure of a TAF1-TAF7 complex in human transcription factor IID reveals a promoter binding module
H Wang, EC Curran, TR Hinds, EH Wang, N Zheng - Cell research, 2014 - nature.com
The general transcription factor IID (TFIID) initiates RNA polymerase II-mediated eukaryotic
transcription by nucleating pre-initiation complex formation at the core promoter of protein …
transcription by nucleating pre-initiation complex formation at the core promoter of protein …
Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation
ZM Ignácio, GZ Réus, HM Abelaira, AL Maciel… - Behavioural Brain …, 2017 - Elsevier
Stress in early life has been appointed as an important phenomenon in the onset of
depression and poor response to treatment with classical antidepressants. Furthermore …
depression and poor response to treatment with classical antidepressants. Furthermore …
SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter
W Shuai, J Wu, S Chen, R Liu, Z Ye, C Kuang, X Fu… - Cancer Letters, 2018 - Elsevier
Abstract Suppressor of variegation 3–9 homolog 2 (SUV39H2) is a member of the SUV39H
subfamily of lysine methyltransferases. Its role in colorectal cancer (CRC) proliferation and …
subfamily of lysine methyltransferases. Its role in colorectal cancer (CRC) proliferation and …
Inhibitors to understand molecular mechanisms of NAD+-dependent deacetylases (sirtuins)
M Lawson, U Uciechowska, J Schemies… - … et Biophysica Acta (BBA …, 2010 - Elsevier
Histone deacetylases (HDACs) are enzymes that cleave acetyl groups from acetyl-lysine
residues in histones and various nonhistone proteins. Unlike the other three of the four …
residues in histones and various nonhistone proteins. Unlike the other three of the four …
N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer
J Yang, P Xu, Z Chen, X Zhang, Y Xia, L Fang, L Xie… - Cancer Letters, 2023 - Elsevier
Despite many advances in treatment over the past few years, the poor 5-year survival rate
and high recurrence rate of gastric cancer (GC) remain unsatisfactory. As the most abundant …
and high recurrence rate of gastric cancer (GC) remain unsatisfactory. As the most abundant …
Chemical protein degradation approach and its application to epigenetic targets
Y Itoh - The Chemical Record, 2018 - Wiley Online Library
In addition to traditional drugs, such as enzyme inhibitors, receptor agonists/antagonists,
and protein‐protein interaction inhibitors as well as genetic technology, such as RNA …
and protein‐protein interaction inhibitors as well as genetic technology, such as RNA …